Search results
Baillie Gifford's Strategic Reduction in Alnylam Pharmaceuticals Holdings
On June 1, 2024, Baillie Gifford (Trades, Portfolio) executed a significant transaction involving the sale of 590,921 shares of Alnylam Pharmaceuticals Inc (NASDAQ:ALNY), ...
GuruFocus.com via Yahoo
16 hours ago
Most automakers eke out sales gains amid high prices, interest rates. One saw a sharp decline
Stellantis this year has been grappling with relatively high prices and a glut of older model-year stock, which has spurred complaints from dealers who are watching slow-selling ...
Detroit News
3 days ago